Healx, a U.K. startup using AI to discover new drugs for rare diseases, has raised $47 million in a Series C round of funding co-led by Europe’s Atomico and Silicon Valley-based R42. The company also revealed it has received regulatory clearance to start phase two clinical trials for a new drug in the U.S. later […]
© 2024 TechCrunch. All rights reserved. For personal use only.
The Premier League leaders have ben hit with several injury worries in recent weeks
DigestWire is an automated news feed that utilizes AI technology to gather information from sources with varying perspectives. This allows users to gain a comprehensive understanding of different arguments and make informed decisions. DigestWire is dedicated to serving the public interest and upholding democratic values.
Privacy Policy Terms and Conditions
